Rotate Your Device

This site doesn't support landscape mode. Please rotate your phone to portrait.

Iris Medicine

Iris Medicine

At Iris, we are pioneering a new RNA modality: small binding RNAs (sbRNAs). The sbRNA platform unlocks multiple therapeutic approaches, from allele-selective inhibition to gene activation to splicing modulation. Our mission is to address a range of serious diseases, beginning with devastating repeat expansion disorders. We are backed by leading venture capital firms, Venrock and Altitude Life Science Ventures - and we're hiring!

Berkeley, California, United States11-50 employeesFounded 2019

Overview

Iris Medicine focuses its services in the pharmaceutical and healthcare industry. The company was founded in 2019 and based in Palo Alto, California.

Tech Stack

Common crawlDnssecContent delivery networkMobile non scaleable contentCommoncrawl top 10mApple mobile web app capableGodaddy sslGodaddyPoyntApacheGoogle Tag ManagerMobile FriendlyOutlook

Funding History

Seed Round

Undisclosed

May 2020

Venrock